Literature DB >> 10439680

[Atrioventricular block secondary to topical ophthalmic beta blockers].

J M Rubín López1, S Hevía Nava, A Veganzones Bayón, V Barriales Alvarez.   

Abstract

It is known that ophthalmic beta-blockers can induce atrioventricular block. In our series of 243 patients with atrioventricular block, 12 were treated with topic ophthalmic timolol. None of them recognized the eye-drops as a treatment. In 7 cases the sinus rhythm was recovered and in 5 a pacemaker was implanted. There is a significant percentage of atrioventricular blocks produced by the ophthalmic beta-blockers that the patient does not recognize as treatment, and 60% of them are reversible. It is important to ask about the use of eye-drops in patients with bradycardia or atrioventricular block.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10439680

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  4 in total

1.  Severe bradycardia and syncope due to topical ophthalmic timolol.

Authors:  U Canpolat; K M Gürses; K Aytemir; A Oto
Journal:  Herz       Date:  2013-01-23       Impact factor: 1.443

2.  Bradyarrhythmias secondary to topical levobunolol hydrochloride solution.

Authors:  Lianjun Lin; Yuchuan Wang; Yan Chen; Meilin Liu
Journal:  Clin Interv Aging       Date:  2014-10-13       Impact factor: 4.458

3.  Management and outcome of topical beta-blocker-induced atrioventricular block.

Authors:  Kazim Serhan Özcan; Bariş Güngör; Damirbek Osmonov; Ahmet Ilker Tekkeşin; Servet Altay; Ahmet Ekmekçi; Ercan Toprak; Ersin Yildirim; Nazmi Çalik; Ahmet Taha Alper; Kadir Gürkan; Izzet Erdinler
Journal:  Cardiovasc J Afr       Date:  2015 Nov-Dec       Impact factor: 1.167

Review 4.  Complete atrioventricular block due to timolol eye drops: a case report and literature review.

Authors:  Zhuoying Wang; Ian Denys; Feng Chen; Lijie Cai; Xuecui Wang; Daniel R Kapusta; Yongliang Lv; Juan Gao
Journal:  BMC Pharmacol Toxicol       Date:  2019-12-02       Impact factor: 2.483

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.